APAX PARTNERS

More in APAX PARTNERS

• Apax to buy TPG’s healthium medtech for $300 million

  This will be London-headquartered Apax’s second healthcare deal in India after its 2007 India debut with an investment in Apollo Hospitals Enterprises.

  

• Advent, Carlyle enter final lap for Mankind deal

  Medical representative turned entrepreneur Ramesh Juneja-founded Mankind — with a heavy focus on selling affordable drugs in the semi-urban and rural markets — is seen as one of the better placed companies to weather an affordable generics push by the government.

  

• Apax leads race for Rs 2,600 crore Sutures deal

  If it goes through, this would only be the third Indian acquisition by Apax, which had earlier acquired IT services companies like iGate and GlobalLogic.

  

• Apax Partners, Carlyle front-runners for Mankind Pharma stake sale

  Apax Partners & Carlyle have been shortlisted and are currently the front-runners for the proposed stake sale by Mankind Pharma, said two sources.

  

• Three horse race - three global PE funds vie for 25% in indegene

  Global private equity funds TA Associates, Kedaara Capital and Apax Partners are in the race to acquire around 25% stake in Indegene, a healthcare IT firm backed by Infosys cofounder NS Raghavan.

  

• Top PE firms join race for Claris Lifesciences’ US business

  The business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma companies.

  

• PE majors initiate talks to acquire diagnostics chain Medall Healthcare

  Medall Healthcare’s top investor Peepul Capital, which owns around 80% stake, and promoter Raju Venkataraman have appointed investment bank Spark Capital to look for buyers.

  

• Global PE funds in talks to buy 80% stake in Medall Healthcare

  Medall Healthcare founder and managing director Raju Venkataraman will also sell a part of its stake to expand the retail chain in southern India.